| 摘要 |
The present invention is directed to a method of treating individuals exhibiting neutropenia or at risk of neutropenia. The method comprises the step of administering to an individual exhibiting neutropenia or at risk of neutropenia, an effective amount of a colony modulating factor derived from bacteria. The colony factor modulator exhibits an immunomodulating effect in humans and promotes a stabilization or increase in neutrophil count. |
